Parasitology · 2013 · 45 citations · 30 references
Veterinary MedicineInfectious DiseasesToxicologyInfectious Disease PathologyInnate ImmunityParasitologyParasitic Disease PathogenesisParasitic PathogenesisProtozoan Host-parasite InteractionsProtozoan PathogenesisToxin-mediated PathogenesisVenom BiologyInfective StagesLeishmaniasis PathogenesisMorphological Changes During GrowthParasite-derived ToxinsSnake Venom ToxicologySwellingToxin CharacterizationUltrastructural Alterations
This paper reports the effects of BnSP-7 toxin, a catalytically inactive phospholipase A2 from Bothrops pauloensis snake venom, on Leishmania (Leishmania) amazonensis. BnSP-7 presented activity against promastigote parasite forms both in the MTT assay, with IC50 of 58.7 μg mL(-1) of toxin, and a growth curve, inhibiting parasite proliferation 60-70% at concentrations of 50-200 μg mL(-1) of toxin 96 h after treatment. Also, the toxin presented effects on amastigotes, reducing parasite viability by 50% at 28.1 μg mL(-1) and delaying the amastigote-promastigote differentiation process. Ultrastructural studies showed that BnSP-7 caused severe morphological changes in promastigotes such as mitochondrial swelling, nuclear alteration, vacuolization, acidocalcisomes, multiflagellar aspects and a blebbing effect in the plasma membrane. Finally, BnSP-7 interfered with the infective capacity of promastigotes in murine peritoneal macrophages, causing statistically significant infectivity-index reductions (P < 0.05) of 20-35%. These data suggest that the BnSP-7 toxin is an important tool for the discovery of new parasite targets that can be exploited to develop new drugs for treating leishmaniasis.
30
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
Ulrich K. Laemmli · Nature · 1970 · 251.6K citations
The substrate specificity of phospholipase A
L.L.M. Van Deenen, Gerard H. De Haas · Biochimica et Biophysica Acta · 1963 · 333 citations